Plain-English translation of NCT07224360 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it is safe for adults with sickle cell disease. You would receive the medication as an injection under your skin over the course of about 16 months. The study wants to find out whether this treatment helps reduce pain crises and is safe to use.
Sickle cell disease causes painful episodes called vaso-occlusive crises that send many patients to the hospital. Researchers are testing this medication to see if it could help prevent these crises or reduce their severity.
You likely qualify if…
You likely don't qualify if…
You would attend regular study visits over about 16 months. First, you would receive gradually increasing doses of the medication over 12 weeks to find the right dose for you. Then you would continue receiving that dose for 52 more weeks. Half of participants will receive the real medication, and half will receive a placebo (dummy injection) to compare how well the treatment works. The study staff will check your health with blood tests and visits to make sure the medication is safe.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States